The metabolic effects of di (2-ethyl hexyl) phthalate medium dose on lipid profiles in serum and liver tissue

Medical Journal of Indonesia

Volumn 20, Issue 1, 2011, Pages 20-26

  Buang, Y ^a,b  

^a Department of Mechanical Engineering   (Indonesia)

^b SAGA UNIVERSITY   (Japan)

Author keywords

Di (2 ethyl hexyl) phthalate; Hyperphospholipids; Lipolysis; Liver lipids; Serum lipids

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE I; CHOLESTEROL; DI (2 ETHYL HEXYL) PHTHALATE; FATTY ACID SYNTHASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; MALATE DEHYDROGENASE (DECARBOXYLATING); PHOSPHATIDATE PHOSPHATASE; PHOSPHOLIPID; PLASTICIZER; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BLOOD STORAGE; BLOOD TRANSFUSION; BODY WEIGHT; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME KINETIC ASSAY; FOOD INTAKE; HISTOLOGY; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOLYSIS; LIVER TISSUE; LIVER WEIGHT; MALE; NONHUMAN; PROTEIN DETERMINATION; RAT; REGULATORY MECHANISM;

EID: 85008975704     PISSN: 08531773     EISSN: 22528083     Source Type: Journal    
DOI: 10.13181/mji.v20i1.425     Document Type: Article

References (24)

1. Hildenbrand SL, Lehmann HD, Wodarz R, Ziemer G, Wendel HP. PVC-plasticizer DEHP in medical products: do thin coatings really reduce DEHP leaching into blood? Perfusion J. 2005; 20: 351-7.
2. Koch HM, Bolt HM, Preuss R, Eckstein R, Weisbach V, Angerer J. Intravenous exposure to di(2-ethylhexyl) phthalate (DEHP): metabolites of DEHP in urine after a voluntary platelet donation. Arch Toxicol. 2005; 79: 689-93.
3. Takahashi Y, Shibata T, Sasaki Y, Fujii H, Bito Y, Suehiro S. Di(2-ethylhexyl) Phthalate Exposure During Cardiopulmonary Bypass. Asian Cardiovasc Thorac Ann 2008; 16: 4-6.
4. Hinberg I. DEHP in Medical Devices: An Exposure and Toxicity Assessment. Research & Surveillance Division, Medical Devices Bureau Therapeutic Products Directorate, Health Canada. 2002.
5. Ghosh J, Das J, Manna P, Sil PC. Hepatotoxicity of di-(2-ethylhexyl) phthalate is attributed to calcium aggravation, ROS-mediated mitochondrial depolarization, and ERK/ NF-êB pathway activation. Free Radic Biol Med. 2010; 49(11):1779-91.
6. Gayathri NS, Dhanya CR, Indu AR, Kurup PA. Changes in some hormones by low doses of di(2-ethylhexyl) phthalate (DEHP), a commonly used plasticizer in PVC blood storage bags and medical tubing. Indian J Med Res. 2004; 119: 139-44.
7. Melnick RL. Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)?. Environ Health Perspect. 2001; 109(5):437-42.
8. Hasmall SC, James NC, Macdonald N, Soames AR, Roberts RA. Species differencies in response to diethylhexyl phthalate: Supression of apoptosis, induction of DNA synthesis and peroxisome proliferator activated receptor alfa-mediated gene expression. Arch Toxicol. 2000; 74: 85-91.
9. Roberts RA, James NH, Hasmall SC, Holden PR, Lambe K, Macdonald N, et al. Apoptosis and proliferation in nongenotoxic carcinogenesis: species differences and role of PPRá. Toxicol. [letter] 2000, 112: 49-57.
10. Buang Y, Cha JY, Nagao K, Wang YM, Inoue N, Yanagita T. Alleviation of fatty liver by á-linolenic acid. J Nutr Sci Vitaminol. 2004; 50: 272-6.
11. Buang Y, Wang YM, Cha JY, Nagao K, Yanagita T. Dietary phosphatidylcholine alleviates fatty liver induced by orotic acid. Nutrition 2005; 21: 867-73.
12. Buang Y, Ola PD, Yanagita T. Dietary shochu kasu alleviates fatty liver induced by orotic acid. Bangladesh J Pharmacol 2010; 5: 57-61.
13. Dixon JB, Bhathal PS, O’Brien PE. Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001;121:91-100.
14. Cotrim HP, Parana R, Braga E. Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history. Am J Gastroenterol. 2000; 95:3018-9.
15. Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, et al. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol. Rev., 2006; 58(4): 726–41.
16. Yanagita T, Satoh M, Enomoto N, Sugano M. Di (2-ethyl hexyl) phthalate enhances hepatic phospholipids synthesis in rats. Bioch. Biophys. Acta 1987; 919: 64-70.
17. Folch J, Lees M, Sloane-Starley GH. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem.1957; 226:497-509.
18. Cha JY, Cho YS, Kim I, Anno T, Rahman SM, Yanagita T. Effect of hesperetin, a citrus flavonoid, on the liver triacylglycerol content and phosphatidate phosphohydrolase activity in orotic acid-fed rats. Plant Foods for Human Nutrition, 2001; 56(4):349-58.
19. Nagao K, Wang YM, Inoue N, Han SY, Buang Y, Noda T, et al. The 10trans, 12cis isomer of cunjugated linoleic acid promotes energy metabolism in OLETF rats. Nutrition. 2003; 19(7-8): 652-6.
20. Hawkes WC. Association of glutathione peroxidase activity with insulin resistance and dietary fat intake during normal pregnancy. The Journal of Clinical Endocrinology & Metabolism. 2004; 89(9): 4772-3.
21. Blankenberg S, Hans J. Rupprecht HJ, Bickel C, Torzewski M, Hafner G, Tiret T, et al. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease. N Engl J Med. 2003; 349:1605-13.
22. Burns KA, Heuvel JPV. Review: Modulation of PPAR activity via phosphorylation. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2007; 1771: 952-60.
23. Latruffe NM, Malki C, Nicholas-Frances V, Jannin B, Clemencet MC, Hansmannel F, et al. Peroxisome proliferatoractivated receptors as physiological sensors of fatty acid metabolism: molecular regulation in peroxisomes. Biochem Soc Transac. 2000; 29: 305-9.
24. Howarth JA, Price SC, Dobrota M, Kentish PA, Hinton RA. Effects on male rats of di (2-ethyl hexyl) phthalate and di-n hexylphthalate administered a lone or in combination. Toxicol [letters] 2001: 35-43.